Identifying Initial Patients

Identifying Initial Patients

The decision to perform bariatric surgery on a severely obese patient requires assessing the risk-benefit ratio in individual cases. Candidates must meet the criteria for LAP-BAND® System surgery and must be able to care for themselves or have an adequate home-based caregiver during the postoperative and long-term follow-up process.

LAP-BAND® System Indications for Use

The LAP-BAND® System is indicated for use in morbidly obese patients who:

  • Have a BMI ≥ 40 kg/m2
  • Have a BMI ≥ 35 kg/m2 with one or more severe comorbid conditions
  • Are ≥ 100 pounds over their estimated ideal body weight
  • Have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modifications programs
  • Are willing to make the commitment to accept significant changes in their eating habits for the rest of their lives
  • Are willing to adhere to post-operative care and follow-up

Contraindications

The LAP-BAND® System is contraindicated for:

  • Non-adult patients (< 18 years of age)
  • Patients with conditions that may render them poor surgical candidates or increase the risk of poor results
  • Patients who are unwilling or unable to comply with dietary restrictions, which are required by this procedure
  • Patients who currently are or may be pregnant (Patients who become pregnant after band placement may require deflation of their bands)

Not all contraindications have been included. Please refer to the Directions for Use for a complete listing of the contraindications.

These Indications for Use are consistent with the NIH/NHLBI Patient Selection criteria.

NIH, NHLBI Patient Selection Criteria1 :

Weight-loss surgery is an option in carefully selected patients who meet the following criteria:

  • Clinically severe obesity (BMI ≥ 40 kg/m2)
  • BMI ≥ 35 kg/m2 with comorbid conditions
  • Have failed less invasive methods of weight loss
  • Are at high risk for obesity-related comorbidity or mortality
  1. Excerpted from NHLBI. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive Summary.

Featured Item

Amanda Before

Amanda Before

High/print resolution image of Amanda before her LAP-BAND® System surgery

 
Privacy Policy | About Us | Contact Us | Sitemap | Risk Information
© 2010 Allergan, Inc., Irvine CA 92612, U.S.A. ® and TM Mark Owned by Allergan, Inc. All rights reserved. Lindora is a registered trademark owned by Lindora, Inc. Curves is a registered trademark owned by Curves International, Inc. COVIDIEN, COVIDIEN with logo and Covidien logo are U.S. and/or internationally registered trademarks of Covidien AG. FITDAY is a registered service mark of Internet Brands, Inc. CareCredit is a registered trademark of CareCredit LLC, General Electric Co, or their subsidiaries. Emmi is a registered trademark owned by Emmi Solutions, LLC. Realize™ is a trademark of Ethicon Endo-Surgery. YouTube is trademark owned by YouTube, LLC.  APC74CS10.
This site is intended for US residents only.